The U.S. Supreme Court ruled on February 20, 2026, that the President cannot use the International Emergency Economic Powers Act (IEEPA) to impose tariffs, as tariffs are considered taxes under the Constitution and such authority rests with Congress. While this decision invalidates tariffs imposed under IEEPA, tariffs under other statutes remain in effect, and the ruling does not reverse existing tariffs or revenue collected. The Court did not address whether importers are entitled to refunds of previously paid IEEPA-based tariffs, which is expected to be addressed by lower courts, potentially leading to a complex and prolonged refund process. Businesses with import exposure are advised to monitor developments, audit tariff liabilities, preserve refund rights, and update contracts to address potential tariff-related risks.
The U.S. Supreme Court ruled in *Learning Resources, Inc. v. Trump* that the tariffs imposed under the International Emergency Economic Powers Act (IEEPA) were unlawful, with Chief Justice Roberts writing the majority opinion. The Court rejected the government's position, stating that IEEPA does not authorize the President to impose tariffs, and sent the issue of refunds back to lower courts. The decision was a 6-3 ruling, with notable opinions including a concurrence by Justice Gorsuch and dissents from Justices Thomas and Kavanaugh.
Neal Katyal, a lawyer for clients involved in the Supreme Court case against Trump's tariffs, stated that the federal government should refund the money collected illegally, with interest. The Supreme Court recently struck down Trump's use of emergency powers to impose tariffs, ruling it unconstitutional, and Katyal emphasized that tariff decisions should be made by Congress, not the president.
Donald Trump claimed that the recent stablecoin briefly losing its peg was part of a "coordinated attack." The article provides various cryptocurrency prices but does not detail the specifics of the attack or its broader implications.
RFK Jr. defended the continued use of glyphosate, stating that a ban would significantly harm U.S. agriculture by reducing crop yields and increasing food prices, despite opposition from some groups advocating for its removal. He emphasized efforts to transition toward regenerative farming practices without destabilizing the food supply and acknowledged that reform will challenge entrenched interests. The backlash highlighted concerns over chemical accountability, transparent labeling, and environmental impacts.
A caller on C-SPAN who sounded like former President Donald Trump called in under the name “John Barron,” raising speculation that it was Trump himself, but C-SPAN clarified it was not the president. The incident sparked discussion about whether Trump would engage in such behavior, while he prepares for his upcoming State of the Union address amid mixed approval ratings. Additionally, the article covers recent developments in Warner Bros. Discovery’s potential sale, Conan O’Brien’s comments on a tragedy involving Rob Reiner’s family, the U.S. Olympic hockey victory, and notable reactions from sports legends.
The U.S. Department of War has introduced an "AI‑first" wartime‑speed agenda through a series of memoranda, directives, and a press release, aimed at accelerating AI development, data integration, and defense innovation. Key initiatives include establishing seven "Pace‑Setting Projects," restructuring the Advana enterprise data platform into a War Data Platform, and unifying the innovation ecosystem under a single CTO-led framework. These measures emphasize rapid experimentation, open architectures, and enhanced data sharing, with significant implications for defense contractors in areas such as procurement, data standards, IP rights, and deployment cycles.
The US Supreme Court invalidated a broad portion of President Trump's tariffs for exceeding his authority, prompting the US Customs and Border Protection agency to stop collecting tariffs imposed under the International Emergency Economic Powers Act. In response, Trump imposed and then raised "global" tariffs to 15% under Section 122 of the Trade Act of 1974, affecting international trade and domestic markets. The EU postponed ratification of its US trade deal pending clarity on Trump's next steps, while countries like France emphasized the need for a united response to the tariffs. The ruling raises questions about potential refunds and the impact on global trade relations.
President Donald Trump threatened to impose higher tariffs on other countries in response to a recent Supreme Court decision that ruled he lacked the authority under the International Emergency Economic Powers Act to impose tariffs. Trump indicated he would explore using other laws to maintain tariffs and previously announced a 10% global tariff, criticizing the court's ruling and expressing dissatisfaction with its decision.
Congresswoman Maxine Dexter announced she is sending Epstein survivor Lisa Phillips to attend the State of the Union on her behalf to emphasize accountability and support for survivors. Dexter stated her intention to highlight that survivors will not be silenced and that the government should be held accountable. Phillips expressed gratitude and emphasized her purpose of advocating for those who lack a voice. Dexter also co-sponsored the Epstein Files Transparency Act to promote the release of relevant files and transparency.
Robert F. Kennedy Jr. and his supporters criticized President Donald Trump's executive order to protect domestic glyphosate herbicide production, expressing concern. The health secretary stated that the administration aims to change course without destabilizing the food supply.
Dr. Oz, head of CMS, warned that increased use of marijuana over alcohol could lead to negative consequences, citing concerns about high-dose hemp and CBD products. He emphasized potential risks associated with strong cannabis-derived products and highlighted ongoing efforts to include CBD coverage under federal health plans, as part of the Trump administration's cannabis rescheduling initiative. Oz has previously supported therapeutic cannabis use and advocated for policy changes to incorporate marijuana into healthcare options.
